Catheter introducer sheaths market projected to reach $2.16 billion by 2030

The catheter introducer sheaths market is forecast to grow from $1.43 billion in 2025 to $1.57 billion in 2026, then to $2.16 billion by 2030, as cardiovascular disease, minimally invasive procedures and safer vascular access needs rise globally. North America held the largest share in 2025, while Asia-Pacific and other regions are expected to add growth.

Why it matters: - Catheter introducer sheaths support safer vascular access during interventional procedures, so demand rises when hospitals perform more cardiovascular and neurointerventional treatments. - The market’s growth tracks a broader shift toward minimally invasive care and lower procedure-related complications. - Rising cardiovascular disease cases are expanding the addressable patient pool for these devices.

What happened: - The Business Research Company published a 2026 market report on catheter introducer sheaths covering market size, trends and a global forecast through 2035. - The market was valued at $1.43 billion in 2025 and is projected to reach $1.57 billion in 2026. - The report forecasts the market will climb to $2.16 billion by 2030, representing an 8.4% CAGR. - North America held the largest share of the market in 2025.

The details: - Historical growth was driven by more interventional cardiology procedures, higher cardiovascular disease prevalence, wider use of catheter-based vascular access, expansion of hospital catheterization labs and greater adoption of minimally invasive surgeries. - Future growth is expected to come from an aging global population, rising demand for safer vascular access technologies, more neurointerventional procedures, growing outpatient interventional surgery volumes and a stronger focus on reducing complications. - The report identifies broader acceptance of minimally invasive interventional techniques, growing preference for hydrophilic and radiopaque sheaths, a push to reduce vascular access complications and development of integrated introducer sheath systems for cardiology and neurovascular procedures as key trends. - Catheter introducer sheaths are hollow medical devices with a dilator and hemostasis valve that help guide catheters into the vascular system or other body cavities. - The devices are designed to reduce vascular injury, bleeding and infection risk while improving procedural efficiency. - The report covers North America, Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 edition includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The report offers a free sample and a full report.

Between the lines: - Cardiovascular disease is the clearest demand driver because catheter introducer sheaths are central to diagnosis and treatment workflows. - North America’s lead suggests a mature procedural market, but the report points to faster incremental gains from emerging regional demand elsewhere. - The device trends highlighted by the report favor products that improve visibility, ease of use and complication control. - Australian Institute of Health and Welfare data cited in the report show the burden behind the market: about 144,000 Australians had heart failure in 2022, cardiovascular disease affected 1.3 million adults, and the condition accounted for nearly 12% of the national disease burden in 2023. - The same data estimated a loss of 666,000 healthy life years in 2023.

What's next: - The market is expected to keep growing as outpatient procedures increase and hospitals adopt tools that make vascular access safer and more predictable. - Product development will likely continue to focus on specialty sheath systems for cardiology and neurovascular use cases. - Regional growth outside North America may become more important as Asia-Pacific and other markets scale procedure volumes.

The bottom line: - Catheter introducer sheaths are moving from a niche accessory to a core enabler of expanding minimally invasive care, with the market set for steady growth through 2030.